MM
Insider
Michael F MacLean
Chief Financial OfficerMichael F MacLean (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $329K of RNA (4,542 sh across 2 lots, as filed), executed Jan 21.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$472K
shares × price, as filed
Last traded
Jan 21
Filed Jan 23
Volume by month
Buys $0
Sells $7.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
2 filings
Sector per market data · by filing · past 12 months
Most traded names
RNA
RNA
RNA · 0 buys · 7 sells
7 filings
Recent filings
RNASALE
Avidity Biosciences, Inc.
View filing →
$329K4,542 sh across 2 lots
Exec Jan 21
Filed Jan 23 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $143K
1,974 sh × $72.23
Exec Jan 7
Filed Jan 9 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $1.3M
30,914 sh × $42.73
Exec Aug 6 2025
Filed Aug 15 2025 · 5:30 PM ET † RNASALE Avidity Biosciences, Inc. View filing → $246K
7,935 sh × $31.06
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $364K
11,151 sh × $32.66
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $4.8M
106,319 sh across 3 lots
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $506K
11,510 sh × $44.00
Exec Sep 23 2024
Filed Sep 23 2024 · 5:30 PM ET